The immunobiology of cancer immunosurveillance and immunoediting

Research output: Contribution to journalReview article

1682 Scopus citations

Abstract

The last fifteen years have seen a reemergence of interest in cancer immunosurveillance and a broadening of this concept into one termed cancer immunoediting. The latter, supported by strong experimental data derived from murine tumor models and provocative correlative data obtained by studying human cancer, holds that the immune system not only protects the host against development of primary nonviral cancers but also sculpts tumor immunogenicity. Cancer immunoediting is a process consisting of three phases: elimination (i.e., cancer immunosurveillance), equilibrium, and escape. Herein, we summarize the data supporting the existence of each of the three cancer immunoediting phases. The full understanding of the immunobiology of cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective immunotherapeutic approaches to control and/or eliminate human cancers.

Original languageEnglish
Pages (from-to)137-148
Number of pages12
JournalImmunity
Volume21
Issue number2
DOIs
StatePublished - Aug 1 2004

Fingerprint Dive into the research topics of 'The immunobiology of cancer immunosurveillance and immunoediting'. Together they form a unique fingerprint.

  • Cite this